tirzepatide lyf Lilly Shows Superiority in SURMOUNT-3 and 4 FDA approves Eli Lilly's tirzepatide

After injection, withdraw the needle straight out

The procedure is quick, taking only a few seconds, and most patients report minimal discomfortsimilar to other intramuscular injections such as vaccines

1 Introduction Incretin peptides are secreted from the intestine after nutrient ingestion and enhance glucose-stimulated insulin secretion ( 2 Weight loss pharmacotherapies 2.1 GLP-1R and GIPR agonism reduce body weight in patients with obesity Early GLP-1R agonists were approved to treat T2D ( The mechanism underlying the impressive weight loss potential of GLP-1R agonists is primarily, if not exclusively, mediated by a reduction in energy intake

Yes, both mazdutide and tirzepatide are approved for weight management in individuals with obesity or overweight with comorbidities, regardless of diabetes status

Primarily, these medications decrease postprandial glucagon secretion, slow gastric emptying, and promote appetite suppression as a treatment for type 2 diabetes and obesity